CSI Market
Sign In | Register

Biolase Inc (BIOL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BIOL Annual Cash Flow →
The table below presents a historical view of Biolase Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
9 Months 		(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Operating Activities
Income-10.71
Depreciation & amortization1.96
Amortization of Other Assets0.36
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.22
Increase (Decrease) in Inventories1.40
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Other Assets-0.29
Share-based Compensation0.95
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-1.06
Recovery Of Sales Returns Allowance-
Provision For Inventory Excess And Obsolescence-
Provision Recoveries For Doubtful Accounts-
Provision For Sales Allowance-
Provision For Sales Returns Allowance-
Provision For Recovery Of Doubtful Accounts-
Amortization Of Discounts On Lines Of Credit-
Increase Decrease In Customer Deposits Liabilities-
Gain Loss Related To Litigation Settlement-
Gain Loss On Issuance Of Warrants To Consultants-
Provision For Sales Returns-
Inventory Write Offs And Disposals-
Patent Litigation Mark To Market-
Expiration Of Warrant Liabilities-0.55
Increase Decrease In Contract With Customer Liability-0.26
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.74
Increase (Decrease) in Accounts Payable and Accrued Liabilities-4.32
Increase (Decrease) in Interest Payable, Net0.00
Increase (Decrease) in Customer Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.65
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.08
Discontinued operations0.00
Net Cash flow from Operating Activities-11.14
Investing Activities
Capital Expenditures-0.07
Sale of Capital Items0.36
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Disposal Of Long Lived Assets-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.29
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.78
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.27
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net2.18
Payments Of Stock Repurchase Costs-
Proceeds From Stock Options And Warrants Exercised-
Proceeds From Collection Of Receivables And Exercise Of Stock Options-
Deposit On Capital Lease-
Payments Of Fees For Shelf Registration-
Proceeds From Sale Of Common Stock Warrants3.02
Cash Paid For Operating Leases0.24
Capital Expenditures Incurred But Not Yet Paid-
Non Cash Right Of Use Assets Obtained In Exchange For Lease Obligation0.08
Principal Payment On Term Loan-0.87
Amount Paid For Debt Issuance Cost-
Fees Paid For Debt Instruments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.71
Effect of exchange rate on cash flow0.02
Discontinued operations0.00
Free Cash Flow-10.85
Total Cash Flow-3.12
4 historic quarters locked

Sign in to unlock the full Biolase Inc cash flow history.

Sign In Create Free Account

About Biolase Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-24-123472

Figures are derived from filed reports and may be restated. Historical data is subject to revision.